Hibiscus Sabdariffa and Centella Asiatica in the Treatment of Anemia by Iron Deficiency

Casa Espirita Terra de Ismael50 enrolled

Overview

The study aims to investigate the prevalence of genetic polymorphisms in adults with iron deficiency and anemia, and the responses to two different treatments: iron sulphate and a composite herbal medicine (Hibiscus sabdariffa plus Centella asiatica). The main outcome will be hemoglobin, measured before and after 6 weeks.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

Conditions

Iron Deficiency Anemia

Interventions

Herbal medicineDRUG

Patients will receive a combination of Hibiscus sabdariffa (powdered dry plant), 200 mg, BID, and Centella asiatica tincture, 40 drops, BID, for 6 weeks.

IronDRUG

Patients will receive iron sulphate, 500 mg, BID, plus orange juice, for 6 weeks.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 50 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age \> 18 y and \< 50 y * A diagnostic of iron deficient anemia Exclusion Criteria: * Severe anemia * Treatment interruption for more than 25% of the 6 weeks * New onset severe adverse symptoms or events * Patient's request

Locations (1)

Laboratorio M. F. Teixeira

Monte Santo de Minas, Minas Gerais, Brazil

Outcomes

Primary Outcomes

Hemoglobin

Hemoglobin will be measured before treatment and after 6 weeks of treatment

Time frame: 6 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.